News

COVID FAQ – Preventative medication and antiviral treatments

20 September 2022

MS Plus has put together a brief Q&A to help you navigate the latest information and advice on COVID preventative medication and antivirals.

MS Plus Executive Manager Client Engagement and Wellbeing Jodi Haartsen is once again joined by Neurologist and Associate Professor Anneke Van Der Walt and Clinical Nurse Consultant Louise Rath from The Alfred.

Please note: this video discusses a preventative medication and antiviral treatments for COVID. However, you may not require treatment – please seek advice from your healthcare team.

 

 

Related News

Media Release

Early results show world-first adaptive trial in action for progressive MS

17 September 2026

A potential treatment for progressive multiple sclerosis (MS) will continue in a world-first multi-arm, multi-stage adaptive trial after showing encouraging early signs, with recruitment set to expand across Australia.

MS News

Alpha lipoic acid shows promise in Stage 1 of Octopus trial in progressive MS

17 September 2026

Results from Stage 1 of the Octopus trial find one of the trial treatments, alpha lipoic acid, shows promise in progressive MS and will continue into trial Stage 2.

MS News

Women and MS: one of the disease’s biggest mysteries

9 September 2026

Why does MS affect women more often than men? How does female biology impact MS activity? Discover what recent research is revealing about risk, hormones, immunity and EBV.

Read More
research grants announcementSimon's story

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

COVID FAQ – Preventative medication and antiviral treatments